Insulin resistance, lipotoxicity and endothelial dysfunction

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 3, 2010, Pages 320-326

  Imrie, Helen ^a   Abbas, Afroze ^a   Kearney, Mark ^a  

^a Chapel Allerton Hospital   (United Kingdom)

Author keywords

Free fatty acid; Nitric oxide; Reactive oxygen species

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; NITRIC OXIDE; RADICAL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ATHEROGENESIS; ATHEROSCLEROSIS; BIOAVAILABILITY; DISEASE ASSOCIATION; DNA MODIFICATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INACTIVATION; ENZYME RELEASE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TOXICITY;

ANIMALS; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; FATTY ACIDS, NONESTERIFIED; HUMANS; INSULIN RESISTANCE; NADPH OXIDASE; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VASCULAR DISEASES;

EID: 76049123402     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.09.025     Document Type: Review

References (83)

1. Booth G.L., Kapral M.K., Fung K., and Tu J.V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368 (2006) 29-36
2. Madala M.C., Franklin B.A., Chen A.Y., Berman A.D., Roe M.T., Peterson E.D., Ohman E.M., Smith Jr. S.C., Gibler W.B., and McCullough P.A. CRUSADE Investigators, Obesity and age of first non-ST-segment elevation myocardial infarction. J. Am. Coll. Bardiol. 52 (2008) 979-985
3. Cubbon R.M., Rajwani A., Abbas A., Gale C.P., Grant P.J., Wheatcroft S.B., Barth J.H., Kearney M.T., and Hall A.S. Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur. J. Cardiovasc. Prev. Rehabil. 14 (2007) 666-671
4. Cubbon R.M., Wheatcroft S.B., Grant P.J., Gale C.P., Barth J.H., Sapsford R.J., Ajjan R., Kearney M.T., and Hall A.S. Evaluation of Methods and Management of Acute Coronary Events Investigators, Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur. Heart J. 28 (2007) 540-545
5. Cubbon R.M., Gale C.P., Rajwani A., Abbas A., Morrell C., Das R., Barth J.H., Grant P.J., Kearney M.T., and Hall A.S. Aspirin and mortality in patients with diabetes sustaining acute coronary syndrome. Diabetes Care 31 (2008) 363-365
6. Cubbon R.M., Abbas A., Wheatcroft S.B., Kilcullen N., Das R., Morrell C., Barth J.H., Kearney M.T., and Hall A.S. EMMACE-2 Investigators, Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event. PloS One 3 (2008) e3483
7. Wheatcroft S.B., Williams I.L., Shah A.M., and Kearney M.T. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet. Med. 20 (2003) 255-268
8. Pyörälä M., Miettinen H., Halonen P., Laakso M., and Pyörälä K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arteriosclerosis Thromb. Vasc. Biol. 20 (2000) 538-544
9. Pyörälä M., Miettinen H., Laakso M., and Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 98 (1998) 398-404
10. Welborn T.A., and Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2 (1979) 154-160
11. Fornengo P., Bosio A., Epifani G., Pallisco O., Mancuso A., and Pascale C. Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors. Diabet. Med. 23 (2006) 775-779
12. Ross R. Atherosclerosis-an inflammatory disease. N. Eng. J. Med. 340 (1999) 115-126
13. Rader D.J., and Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 451 (2008) 904-913
14. Creager M.A., Cooke J.P., Mendelsohn M.E., Gallagher S.J., Coleman S.M., Loscalzo J., and Dzau V.J. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86 (1990) 228-234
15. Clapp B.R., Hingorani A.D., Kharbanda R.K., Mohamed-Ali V., Stephens J.W., Vallance P., and MacAllister R.J. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc. Res. 64 (2004) 172-178
16. Tanner F.C., Meier P., Greutert H., Champion C., Nabel E.G., and Lüscher T.F. Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 101 (2000) 1982-1989
17. Monastyrskaya E., Folarin N., Malyshev I., Green C., and Andreeva L. Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stress. Nitric Oxide 7 (2002) 127-131
18. Schäfer A., Wiesmann F., Neubauer S., Eigenthaler M., Bauersachs J., and Channon K.M. Rapid regulation of platelet activation in vivo by nitric oxide. Circulation 109 (2004) 1819-1822
19. V Schächinger M.B., and Britten A.M. Zeiher, Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
20. Bugiardini R., Manfrini O., Pizzi C., Fontana F., and Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiogram. Circulation 109 (2004) 2518-2523
21. Kim J.A., Montagnani M., Koh K.K., and Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113 (2006) 1991-19881
22. Murphy C., Kanaganayagam G.S., Jiang B., Chowienczyk P.J., Zbinden R., Saha M., Rahman S., Shah A.M., Marber M.S., and Kearney M.T. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 936-942
23. Williams I.L., Chowienczyk P.J., Wheatcroft S.B., Patel A., Sherwood R., Momin A., Shah A.M., and Kearney M.T. Effect of fat distribution on endothelial-dependent and endothelial-independent vasodilatation in healthy humans. Diabetes Obesity and Metabolism 8 (2006) 296-301
24. Melikian N., Chowienczyk P., MacCarthy P.A., Williams I.L., Wheatcroft S.B., Sherwood R., Gale C., Shah A.M., and Kearney M.T. Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome. Atherosclerosis 197 (2008) 375-382
25. Williams I.L., Chowienczyk P.J., Wheatcroft S.B., Patel A.G., Sherwood R.A., Momin A., Shah A.M., and Kearney M.T. Endothelial function and weight loss in obese humans. Obesity Surgery 15 (2005) 1055-1060
26. Melikian N., Kearney M.T., Thomas M.R., De Bruyne B., Shah A.M., and MacCarthy P.A. A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve. Eur. Heart J. 28 (2007) 2188-2194
27. Momin A., Melikian N., Wheatcroft S.B., Grieve D., John L.C., El Gamel A., Marrinan M.T., Desai J.B., Driver C., Sherwood R., Shah A.M., and Kearney M.T. The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 134 (2007) 335-341
28. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., and Baron A.D. Obesity/Insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97 (1996) 2601-2610
29. Laine H., Yki-Jarvinen H., Kirvela O., Tolvanen T., Raitakari M., Solin O., Haaparanta M., Knuuti J., and Nuutila P. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J. Clin. Invest. 101 (1998) 1156-1162
30. Tack C.J., Ong M.K., Lutterman J.A., and Smits P. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 41 (1998) 569-576
31. Westerbacka J., Vehkavaara S., Bergholm R., Wilkinson I., Cockcroft J., and Yki-Järvinen H. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes 48 (1999) 821-827
32. Williams I.L., Wheatcroft S.B., Shah A.M., and Kearney M.T. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 754-756
33. Noronha B.T., Li J.M., Wheatcroft S.B., Shah A.M., and Kearney M.T. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes 54 (2005) 1082-1089
34. Wheatcroft S.B., Shah A.M., Li J.M., Duncan E., Noronha B.T., Crossey P.A., and Kearney M.T. Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor. Diabetes 53 (2004) 2645-2652
35. Duncan E.R., Walker S.J., Ezzat V.A., Wheatcroft S.B., Li J.M., Shah A.M., and Kearney M.T. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E1311-9.4 (abstract)
36. Duncan E.R., Crossey P.A., Walker S., Anilkumar N., Poston L., Douglas G., Ezzat V.A., Wheatcroft S.B., Shah A.M., and Kearney M.T. Effect of endothelium-specific insulin resistance on endothelial function in vivo. Diabetes 57 (2008) 3307-3314
37. Vicent D., Ilany J., Kondo T., Naruse K., Fisher S.J., Kisanuki Y.Y., Bursell S., Yanagisawa M., King G.L., and Kahn C.R. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest. 111 (2003) 1373-1380
38. Michel T., and Feron O. Nitric oxide synthases: which, where, how, and why?. J. Clin. Invest. 100 (1997) 2146-2152
39. Kuboki K., Jiang Z.Y., Takahara N., Ha S.W., Igarashi M., Yamauchi T., Feener E.P., Herbert T.P., Rhodes C.J., and King G.L. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101 (2000) 676-681
40. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
41. Yoshizumi M., Perrella M.A., Burnett Jr. J.C., and Lee M.E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73 (1993) 205-209
42. Wheatcroft S.B., Kearney M.T., Shah A.M., Grieve D.J., Williams I.L., Miell J.P., and Crossey P.A. Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1. Diabetes 52 (2003) 2075-2082
43. Montagnani M., Ravichandran L.V., Chen H., Esposito D.L., and Quon M.J. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol. Endocrinol. 16 (2002) 1931-1942
44. Zeng G., and Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98 (1996) 894-898
45. Zeng G., Nystrom F.H., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H., and Quon M.J. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101 (2000) 1539-1545
46. Kearney M.T., Cowley A.J., Stubbs T.A., and Macdonald I.A. Effect of a physiological insulin infusion on the cardiovascular responses to a high fat meal: evidence supporting a role for insulin in modulating postprandial cardiovascular homoeostasis in man. Clin. Sci. 91 (1996) 415-423
47. Kearney M.T., Cowley A.J., Stubbs T.A., Evans A., and Macdonald I.A. Depressor action of insulin on skeletal muscle vasculature: a novel mechanism for postprandial hypotension in the elderly. J. Am. Coll. Cardiol. 31 (1998) 209-217
48. Abbas A., Imrie H., Viswambharan H., Rajwani A., Cubbon R.M., Kahn M.B., Wheatcroft S.B., and Kearney M.T. Dietary-induced obesity in mice results in metabolic and vascular insulin-like growth factor-1 (IGF-1) resistance. Circulation 118 (2008) S_465 (abstract)
49. Kahn M., et al. Insulin resistance is associated with a reduction in circulating endothelial progenitor cells (EPCs) and impaired endothelial regeneration following wire-induced vascular injury. J. Am. Coll. Cardiol. 53 (2009) A434 (abstract)
50. Symons J.D., McMillin S.L., Riehle C., Tanner J., Palionyte M., Hillas E., Jones D., Cooksey R.C., Birnbaum M.J., McClain D.A., Zhang Q.J., Gale D., Wilson L.J., and Abel E.D. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ. Res. 104 (2009) 1085-1094
51. Molnar J., Yu S., Mzhavia N., Pau C., Chereshnev I., and Dansky H.M. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ. Res. 96 (2005) 1178-1184
52. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
53. Houstis N., Rosen E.D., and Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006) 944-948
54. Alp N.J., and Channon K.M. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 413-420
55. Cave A.C., Brewer A.C., Narayanapanicker A., Ray R., Grieve D.J., Walker S., and Shah A.M. NADPH oxidases in cardiovascular health and disease. Antioxid. Redox. Signal. 8 (2006) 691-728
56. Lassègue B., Sorescu D., Szöcs K., Yin Q., Akers M., Zhang Y., Grant S.L., Lambeth J.D., and Griendling K.K. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88 (2001) 888-894
57. Selemidis S., Sobey C.G., Wingler K., Schmidt H.H., and Drummond G.R. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacology and Therapeutics 120 (2008) 254-291
58. Selemidis S., Dusting G.J., Peshavariya H., Kemp-Harper B.K., Drummond G.R., and Nitric oxide suppresses N. oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc. Res. 75 (2007) 349-358
59. Bendall J.K., Rinze R., Adlam D., Tatham A.L., de Bono J., Wilson N., Volpi E., and Channon K.M. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ. Res. 100 (2007) 1016-1025
60. Ray R., Zhang M., Brewer A.C., and Shah A.M. Effects of endothelial-targeted overexpression of Nox4 on vascular tone and blood pressure in mice. Circulation 116 (2007) II-51 (abstract)
61. Görlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., Busse R., and A gp91phox containing N. oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87 (2000) 26-32
62. Jung O., Schreiber J.G., Geiger H., Pedrazzini T., Busse R., Brandes R.P., and gp91phox-containing N. oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109 (2004) 1795-1801
63. Dworakowski R., Anilkumar N., Zhang M., and Shah A.M. Redox signalling involving NADPH oxidase-derived reactive oxygen species. Biochem. Soc. Trans. 34 (2006) 960-964
64. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., and Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192 (2000) 1001-1014
65. Bernal-Mizrachi C., Gates A.C., Weng S., Imamura T., Knutsen R.H., DeSantis P., Coleman T., Townsend R.R., Muglia L.J., and Semenkovich C.F. Vascular respiratory uncoupling increases blood pressure and atherosclerosis. Nature 435 (2005) 502-506
66. Silver A.E., Beske S.D., Christou D.D., Donato A.J., Moreau K.L., Eskurza I., Gates P.E., and Seals D.R. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 115 (2007) 627-637
67. Fortuño A., San José G., Moreno M.U., Beloqui O., Díez J., and Zalba G. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 55 (2006) 209-215
68. Guzik T.J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., and Channon K.M. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 9 (2002) 1656-1662
69. Dworakowski R., Walker S., Momin A., Desai J., El-Gamel A., Wendler O., Kearney M.T., and Shah A.M. Reduced nicotinamide adenine dinucleotide phosphate oxidase-derived superoxide and vascular endothelial dysfunction in human heart failure. J. Am. Coll. Cardiol. 51 (2008) 1349-1356
70. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114 (2004) 1752-1761
71. Steinberg H.O., and Baron A.D. Vascular function, insulin resistance and fatty acids. Diabetologia 45 (2002) 623-634
72. Swislocki A.L., Chen Y.D., Golay A., Chang M.O., and Reaven G.M. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 30 (1987) 622-626
73. Rizzo M., Kotur-Stevuljevic J., Berneis K., Spinas G., Rini G.B., Jelic-Ivanovic Z., Spasojevic-Kalimanovska V., and Vekic J. Atherogenic dyslipidemia and oxidative stress: a new look. Transl. Res. 153 (2009) 217-223
74. Fu P., and Birukov K.G. Oxidized phospholipids in control of inflammation and endothelial barrier. Transl. Res. 153 (2009) 166-176
75. Schönfeld P., and Wojtczak L. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic. Biol. Med. 45 (2008) 231-241
76. Steinberg H.O., Paradisi G., Hook G., Crowder K., Cronin J., and Baron A.D. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49 (2000) 1231-1238
77. Karman R.J., Gupta M.P., Garcia J.G., and Hart C.M. Exogenous fatty acids modulate the functional and cytotoxic responses of cultured pulmonary artery endothelial cells to oxidant stress. J. Lab. Clin. Med. 129 (1997) 548-556
78. Chinen I., Shimabukuro M., Yamakawa K., Higa N., Matsuzaki T., Noguchi K., Ueda S., Sakanashi M., and Takasu N. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology 148 (2007) 160-165
79. Du X., Edelstein D., Obici S., Higham N., Zou M.H., and Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J. Clin. Invest. 116 (2006) 1071-1080
80. Maloney E., Sweet I.R., Hockenbery D.M., Pham M., Rizzo N.O., Tateya S., Handa P., Schwartz M.W., and Kim F. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler. Thromb. Vasc. Biol. 29 (2009) 1370-1375
81. Kim F., Tysseling K.A., Rice J., Pham M., Haji L., Gallis B.M., Baas A.S., Paramsothy P., Giachelli C.M., Corson M.A., and Raines E.W. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 989-994
82. Kim F., Pham M., Luttrell I., Bannerman D.D., Tupper J., Thaler J., Hawn T.R., Raines E.W., and Schwartz M.W. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100 (2007) 1589-1596
83. Kanda T., Brown J.D., Orasanu G., Vogel S., Gonzalez F.J., Sartoretto J., Michel T., and Plutzky J. PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J. Clin. Invest. 119 (2009) 110-124